Prostate cancer is one of the most common health hazards for men worldwide, specifically in
Western countries. Rapid prostate cancer screening by analyzing the prostate-specific …

Cancer is among the leading causes of death and an important barrier to improving life
expectancy globally. Prostate cancer is the second most common cancer in men worldwide …

Prostate cancer represents one of the most common forms of cancer affecting men across
the globe. Due to late diagnosis of this disease, the mortality of this condition is very high …

The fabrication and development of nanomaterials for the treatment of prostate cancer have
gained significant appraisal in recent years. Advancements in synthesis of organic and …

Despite the significant progress in the discovery of biomarkers and the exploitation of
technologies for prostate cancer (PCa) detection and diagnosis, the initial screening of these …

Prostate cancer has a high incidence in men and remains the second cause of mortality due
to cancer worldwide. As the development of the disease is greatly correlated to age, the …

Carcinoembryonic antigen (CEA) is a prominent cancer biomarker that allows for early
diagnosis of various cancers. Present immunoassays techniques help quantify such target …

Background The current progressive increase in the cancer burden of prostate cancer
requires the exploration of new diagnostic and therapeutic approaches. Nanobodies are …

At the onset of cancer a selective protein or gene based biomarker gets elevated or modified
in body fluids or tissues. Early diagnosis of these markers can greatly improve the survival …

Early cancer diagnosis remains the holy-grail in the battle against cancers progression.
Tainted with debates and medical challenges, current therapeutic approaches for prostate …